MEDERMA NAMED THE #1 PHARMACIST RECOMMENDED BRAND FOR SCAR AND STRETCH MARK TREATMENTS BY PHARMACY TIMES AND U.S. NEWS & WORLD REPORT. Mederma® is recognized as #1 pharmacist recommended brand for scar care 15 years in a row and third year for stretch mark treatments
Merz Aesthetics, a division of Merz North America, announces today that Mederma® has been named the #1 Pharmacist Recommended Brand in the scar care and stretch mark treatment categories for 2017-2018 by Pharmacy Times and U.S. News & World Report. This is the 15th year Mederma® has been recognized for scar care and third year for stretch marks treatments.
For the past six years, U.S. News & World Report has joined Pharmacy Times in honoring the #1 Pharmacist Recommended brands. Top recommended brands were identified by Pharmacy Times and U.S. News & World Report through a national survey of more than 3,000 pharmacists from late 2016 to early 2017. This survey is the most comprehensive research of its kind, covering 163 product categories commonly sought by consumers.
“We are honored to have Mederma® recognized by these prestigious media outlets,” commented Jim Hartman, Vice President and U.S. Head of Merz Aesthetics Marketing and OTC. “This accolade is a testament to our brand heritage and mission to deliver a wide-range of scar and stretch mark products to meet the needs of our consumers.”
Mederma® offers a range of over-the-counter products to improve the appearance of old and new scars caused by cuts, scrapes, burns, acne and surgery including Mederma® Advanced Scar Gel, Mederma® Scar Cream Plus SPF 30, Mederma® PM Intensive Overnight Scar Cream, Mederma® For KidsTM. Mederma® Stretch Marks Therapy, a nourishing cream formula to help prevent and improve the appearance of new and existing stretch marks. The latest addition to the Mederma® portfolio is Mederma® Quick Dry Oil, a multi-use product for use on scars, stretch marks, uneven skin tone and dry skin.
Mederma® scar care and stretch marks products, as well as the Mederma® AG and Mederma® Spezial product ranges are currently available for purchase online at Amazon.com and at CVS, Target, Walmart, Walgreens and Rite Aid stores.
About Pharmacy Times 2017 Survey of Pharmacists’ OTC Recommendations
The 2017 Pharmacy Times Survey of Pharmacists’ OTC Recommendations was conducted through an Internet-based survey about preferences on more than 1,100 OTC brands spanning 163 product categories. Each pharmacist was provided with a subset of the 163 categories and, for each category, was given a list of products/brands and asked to choose which one they recommended most often and the number of
times they recommended products in each category on a monthly basis. “Write-in” responses were allowed. A total of 3,076 pharmacists participated in the survey and incentives were offered. The survey was opened on December 1, 2016 and closed on March 1, 2017. Results were tabulated by mid-March 2017. Full results are posted on www.OTCGuide.net and are published in the June issue of Pharmacy Times.
About Merz Aesthetics
Merz Aesthetics is a division of Merz North America and offers a wide-ranging portfolio of treatment options including Device (Ultherapy®, CellfinaTM System, DESCRIBE® PFD Patch), Injectables (Xeomin®, Radiesse® Volumizing Filler, Belotero Balance®, Asclera®) and Skincare (NEOCUTIS®, Mederma®) that enables physicians to meet the needs of a broader range of patients and their skin concerns. To learn more about Merz Aesthetics and their Device offerings, please visit www.merzusa.com/aesthetics- otc.
About Merz North America
Merz North America is a specialty healthcare company dedicated to the development and marketing of innovative quality products for physicians and patients across the United States and Canada. Merz products are distributed through two divisions, Aesthetics and Neurosciences, and are developed with the goal of improving patients’ health and quality of life by delivering therapies that bring about real progress. Merz North America is a privately-held company based in Raleigh, North Carolina. To learn more about Merz North America, please visit www.merzusa.com.
MEDERMA is a registered trademark of Merz North America, Inc.
With approximately 3,000 employees and 34 subsidiaries worldwide, Merz is a global leader in Aesthetics and Neurotoxins. Privately held for more than 100 years, the company is distinguished by its in-house research and development, solid financial strength and continuous growth. Complementing its unique portfolio of products for minimally invasive and non-invasive skin rejuvenation and tightening, Merz also develops neurotoxin therapy for the treatment of movement disorders. Skincare products and a range of OTC medicines are also included in offerings from the company, which is headquartered in Frankfurt, Germany. In fiscal year 2016/17, the Merz Pharma Group generated revenue of EUR 1,023.2 million. More information is available at www.merz.com.
06.13.2017 [ 0 KB ]
Merz North America